Cell Cycle · 2014 · 55 citations · 28 references
Life SciencesDevelopmental BiologyEndocrinologyAgingMetabolic RegulationReproductive EndocrinologyBody Composition ChangesInsulin Signaling In MetabolismNeonatal EndocrinologyNeonatal PhysiologyPrenatal DevelopmentRodent EndocrinologyAge-related Endocrine ChangeAging-related Hormonal DeclineAntidiabetic Drug TherapyBody Weight RegulationInsulin-like SignalingLife Span ExtensionSexual Differentiation DisruptionTransgenic Mice
The perinatal (prenatal and early neonatal) period is a critical stage for hypothalamic programming of sexual differentiation as well as for the development of energy and metabolic homeostasis. We hypothesized that neonatal treatment with antidiabetic drug biguanide metformin would positively modify regulation of growth hormone--IGF-1--insulin signaling pathway slowing down aging and improving cancer preventive patterns in rodents. To test this hypothesis male and female 129/Sv mice were s.c. injected with metformin (100 mg/kg) at the 3rd, 5th and 7th days after birth. Metformin-treated males consumed less food and water and their body weight was decreased as compared with control mice practically over their entire lifespan. There were no significant differences in age-related dynamics of food and water consumption in females and they were heavier than controls. The fraction of mice with regular estrous cycles decreased with age and demonstrated a tendency to decrease in the females neonatally treated with metformin. Neonatal exposure to metformin practically failed to change the extent of hormonal and metabolic parameters in blood serum of male and female mice. In males, neonatal metformin treatment significantly increased the mean life span (+20%, P < 0.05) and slightly increased the maximum life span (+3.5%). In females, the mean life span and median in metformin-treated groups were slightly decreased (-9.1% and -13.8% respectively, P > 0.05) in comparison to controls, whereas mean life span of last 10% survivors and maximum life span were the same as in controls. Almost half (45%) of control male mice and 71.8% male mice neonatally exposed to metformin survived up to 800 d of age, the same age was achieved by 54.3% of mice in control female group and 30% of metformin-treated females (P < 0.03). Thus, neonatal metformin exposure slows down aging and prolongs lifespan in male but not in female mice.
28
Practical methods of optimization
Mathematics and Computers in Simulation · 1988 · 5.9K citations
PLEIOTROPY, NATURAL SELECTION, AND THE EVOLUTION OF SENESCENCE
George C. Williams · Evolution · 1957 · 4.3K citations
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
Randy Strong, Z. Dave Sharp, James F. Nelson et al. · Nature · 2009 · 3.7K citations · Full text